Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

GTx, Inc. to Participate in the Stifel 2017 Healthcare Conference

Posted on: 08 Nov 17

GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, will present a company overview at the Stifel 2017 Healthcare Conference on Wednesday, November 15, 2017 at 9:30 am EST. The conference is being held at the Lotte New York Palace Hotel in New York City.

A simultaneous webcast of the presentation can be accessed by visiting the investor relations section of the GTx website at A replay of the presentation will also be available and archived on the site for 30 days.

About GTx

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules for the treatment of serious medical conditions, including treatments for stress urinary incontinence and prostate cancer.

View source version on

Business Wire

Last updated on: 08/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.